| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 684409 | 18-Norestr-4-en-3-one, 17-ethynyl-13-ethyl- 17.beta.-hydroxy-,2-[(9,10-dihydro-10-oxo-4-acridinyl)carbonyl]hydrazone | 0.0480633950058471 | -0.091901262 |
| NSC 685285 | Null | 0.0480633950058471 | -0.28125415 |
| NSC 686551 | Null | 0.0480633950058471 | -0.082415615 |
| NSC 689626 | Null | 0.0480633950058471 | 0.21374362 |
| NSC 693169 | Null | 0.0480633950058471 | -0.061047101 |
| NSC 699934 | Null | 0.0480633950058471 | -0.23922066 |
| NSC 701102 | 2H-1-Benzopyran-2-one, 6-chloro-3-[6-chloroimidazo[1,2-a]pyridin-2-yl]- | 0.0480633950058471 | -0.22284815 |
| NSC 709358 | 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol | 0.0480633950058471 | 0.20819072 |
| NSC 718781 | Erlotinib hydrochloride | 0.0480633950058471 | 0.47764609 |
| NSC 719667 | 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one | 0.0480633950058471 | -0.1230386 |